Morton J. Kern

picture of Morton J. Kern

School of Medicine

Chief of Medicine, VA Long Beach Health Care System
School of Medicine

M.D., Mt. Sinai School of Medicine, New York, 1976

Phone: (562) 826-8000 x6064

University of California, Irvine
VA Long Beach
5901 E 7th Street
Bldg 1, rm 417
Long Beach, CA 90822
Research Interests
Interventional Cardiology Education and Practice, Acute coronary syndromes, Hemodynamics, Hypertrophic Cardiomyopathy
Academic Distinctions
2014 Master, Society of Cardic Angiography and Intervention
2013 Elite Reviewer, Journal of American College of Cardiology
2012 Elite Reviewer, Cathand Cardiovascular Intervention
2011- ‘Best Doctors in America’, peer listing US News and World Report
2010 ‘Best Doctors in America’, peer listing US News and World Report
2010 ‘Best Cardiologists in Orange County’, peer listing, OC Register
2009 Simon Dack Award, Outstanding Scholarship from the JACC
2008 Southern California ‘Super’ Doctors (Cardiology), Orange Co Mag
1993-2005 Top Doctors in St. Louis (Cardiology), St. Louis Magazine
2004 Elite Reviewer, Journal of American College of Cardiology
1989 Certificate of Proficiency, SCAI
1976 Merck Scholarship Book Award
1975 Alpha Omega Alpha Medical Honor Society
2014-Chief, Medicine Health Care Group, VA Long Beach Health Care System
2009-14 Chief, Division of Cardiology, VA Long Beach Health Care System2006- Associate Chief, Division of Cardiology, University California Irvine
2006- Professor of Medicine, Univ Calif Irvine, Orange, California
2008-2009 Director, Clinical Research, Long Beach Memorial Hospital 2005-2006 Director, Clinical Research, PCA, Costa Mesa, California
2005-2006 Voluntary Clinical Professor of Medicine, Cardiology, USC1991-2004 Professor of Medicine, St. Louis University School of Medicine1989-2004 Director, J.G. Mudd Cardiac Catheterization Lab, St. Louis Univ.1988-1991 Associate Professor of Medicine, SLU
1985-1993 Director Cardiac CAth lab, John Cochran VA , St. Louis
1985-1989 Associate Director, Cardiac Catheterization Laboratory, SLU
1985-1988 Assistant Professor of Medicine, Medicine/Cardiology, SLU
1984-1985 Associate Director, Cardiac Cath Lab. Audie L. Murphy VA UTSA
1982-1985 Assistant Professor of Medicine, Cardiology, Univ Texas HSC, San Antonio, Texas
1981-1982 Junior Associate, Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Research Abstract
Hoang KC, Thompson C, Patel PM, Hendricks MJ, Wong ND, Kern MJ. Association of modified syntax score with nirs lipid core coronary plaque assessment in patients with coronary artery disease: data from the color registry. Soc Cardiac Angiography and Intervention Scientific Sessions, Cath and Cardiovascular Interven, 75:S117: 2010.

Hoang KC, Thompson C, Patel PM, Hendricks MJ, Wong ND, Kern MJ. Association of serum lipids with NIRS lipid core coronary plaque burden in patients with coronary artery disease: Data from the COLOR registry. Soc Cardiac Angiography and Intervention Scientific Sessions, Cath and Cardiovascular Interven, 75:S107: 2010.

Townsend JC, Steinberg DH, Nielsen CD, Todoran TM, Zwerner PL, McCarty CP, McManus WJ, Sneed JD, Patel CP, Leonardi RA, Brilakis ES, Shunk KA, Goldstein JA, Kern MJ. Intracoronary lipid burden at bifurcations: Results from the COLOR Registry. Circulation. 2010;122:A1
Kern MJ and Seto AH (Eds.). The SCAI Interventional Cardiology Board Review, 3rd edition. Wolters Kluwer/Lippincott Williams and Wilkens, Philadelphia, PA, 490 pages, 2018.

Kern MJ, Lim MJ, Sorrajja P (Eds). The Interventional Cardiac Catheterization Handbook. 4th Edition, Elsevier, Philadelphia, 2017, 458 pages.

Kern MJ, Sorajja PS, Lim MJ. (Ed.) The Cardiac Catheterization Handbook, 6th Edition, Elsevier, Philadephia, 2016, 494 pages

Kern MJ, Seto AH. Chap 20. Cardiac Catheterization, Cardiac Angiography, and Coronary Blood Flow and Pressure Measurements in 14th Edition of Hurst’s the Heart. Editor, Fuster V, Harrington RA, Narula J, Eapen AJ. p606-656; 2017

Selected from 305 peer reviewed publications
Seto AH, Kern MJ. Chapter 27, Application of Intracoronary Physiology: Use of Pressure and Flow Measurements in Cardiovascular Catheterization and Intervention: A Textbook of Coronary, Peripheral,
and Structural Heart Disease, Second Edition, Edited by D. Mukherjee, E. Bates, M. Roffi, RA Lange, 2017, CRC Press, London.

Kern MJ. Coronary Blood Flow, CathSAP5, ACC, 2017

Kern MJ. Right and Left heart hemodynamics, CathSAP5, ACC, 2017

136. May 2017
iFR - The New Kid in Coronary Physiology. Results of 2 Outcome Trials: DEFINE-FLAIR and SWEDEHEART

137. June 2017
Interventional Coronary Physiology: A 30-Year Overnight Success Story

138. July 2017
An Implantable Pulmonary Artery Pressure Monitoring Sensor to Improve Outcomes in Heart Failure Patients

139. August 2017
Nitroglycerin Revisited: Update for the Cath Lab*

140. September 2017
Time to Review Your Radial Practice for Best Results

141. October 2017
When Should You Perform Coronary Angiography in a Patient With New Onset CHF?

Kern MJ, Samady H. Current Concepts of Integrated Coronary Physiology in the Cath Lab, J Am Coll Cardiol 2010;55:173–85

Lofti A, Jeremias A, Fearon WF, Feldman MD, Mehran R, Messenger JAC, Grines CL, Dean LS, Kern MJ, Klein LW. Expert consensus Statement on the Use of Fractional Flow Reserve, Intravascular Ultrasound, and Optical Coherence Tomography: A Consensus Statement of the Society of Cardiovascular Angiography and Interventions. Cath and CV Interventions 2014;83:509-518

Kern MJ. Reconciling Poststenotic Pressure with Hyperemic Flow: Comparing Coronary Flow Reserve, Instantaneous Wave-Free Ratio, and Fractional Flow Reserve. Circ Cardiovascular interventions 2014;7:432-434

Kern MJ. Seeing and Not Believing: Understanding the Visual-Functional Mismatch between Angiography and FFR. Cath and Cardiovascular Interventions 2014: 84;414-415
2017- [FLAIR] Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation (FLAIR)- Prospective, Multi-center, Double Blind, Randomized Study to Test the Safety of Deferral of Stenting in Physiological Non-significant Lesions in a Clinical Population of Intermediate Stenoses using iFR and FFR 2016-Co-investigator, A Double-Blind, Randomized, Multi-center, Placebo-controlled, Parallel-group Study to Determine the Effects of Evolocumab (AMG 145) Treatment on Atherosclerotic Disease Burden as Measured by Intravascular Ultrasound in Subject Undergoing Coronary Catheterization (Amgen Protocol # 20120153) 2016-Co-investigator, A Randomized, Multi-center Clinical Evaluation of the Osprey Medical AVERT System to Assess Contrast Media Volume Reduction and Incidence of Contrast Induced Nephropathy. Osprey Medical.
Professional Societies
2000 Fellow, American Heart Association (Council of Clinica
1989 Fellow, Council on Clinical Cardiology (AHA)
2014 Master, Society for Cardiac Angiography
1984 Fellow, American College of Cardiology
Graduate Programs
Cardiovascular Disease (IM)

Internal Medicine

Interventional Cardiology (IM)

Last updated